Related links
Case Number: 202006-129284
The insurer denied coverage for the medication Dupixent injections 200. The appeal letter by Dr. Jacob Levitt states the patient has been diagnosed with
Learn more
Dupilumab Use in Moderate-to-Severe Atopic Dermatitis
by ML Buck Cited by 6 The efficacy of dupilumab in adults with atopic dermatitis, as well as its approval for the treatment of moderate-to-severe asthma in
Learn more
2018 Annual Report
Apr 28, 2019 Dupixent achieved $922 million in 2018 global net product sales, as Response Letter regarding the Chemistry, Manufacturing, and Controls
Learn more